首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   90228篇
  免费   8510篇
  国内免费   4565篇
耳鼻咽喉   1042篇
儿科学   980篇
妇产科学   1387篇
基础医学   11813篇
口腔科学   2021篇
临床医学   9151篇
内科学   14905篇
皮肤病学   1455篇
神经病学   5434篇
特种医学   3337篇
外国民族医学   17篇
外科学   12014篇
综合类   11998篇
现状与发展   15篇
一般理论   7篇
预防医学   5937篇
眼科学   2239篇
药学   8973篇
  34篇
中国医学   3434篇
肿瘤学   7110篇
  2024年   216篇
  2023年   1046篇
  2022年   2321篇
  2021年   2973篇
  2020年   2270篇
  2019年   2052篇
  2018年   2576篇
  2017年   2300篇
  2016年   2133篇
  2015年   2913篇
  2014年   3585篇
  2013年   3981篇
  2012年   5346篇
  2011年   5547篇
  2010年   3760篇
  2009年   3268篇
  2008年   4072篇
  2007年   4135篇
  2006年   3726篇
  2005年   3263篇
  2004年   2512篇
  2003年   2283篇
  2002年   2077篇
  2001年   5233篇
  2000年   5081篇
  1999年   4405篇
  1998年   1619篇
  1997年   1254篇
  1996年   821篇
  1995年   686篇
  1994年   605篇
  1993年   488篇
  1992年   2012篇
  1991年   1752篇
  1990年   1603篇
  1989年   1545篇
  1988年   1348篇
  1987年   1222篇
  1986年   1087篇
  1985年   910篇
  1984年   603篇
  1983年   468篇
  1982年   258篇
  1981年   189篇
  1980年   141篇
  1979年   284篇
  1978年   88篇
  1974年   79篇
  1973年   99篇
  1972年   78篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
Experimental study on the immunosuppressive effects of gui zhi tang   总被引:1,自引:0,他引:1  
X F Lu 《中西医结合杂志》1989,9(5):283-5, 262
In this paper the immunosuppressive effects of Gui Zhi Tang (a famous Chinese medicine) on the murine immune functions are reported. Varying dosages of Gui Zhi Tang administrated orally, i.p. and i.m. were able to inhibit the amounts of PFC, SRFC and the DTH response induced by BSA and the proliferation response of murine spleen cells to Con A and LPS. Further studies showed that Gui Zhi Tang had the inhibitory effect on Interleukin-2 production of murine spleen cells, which might be one of the mechanisms leading to the immunosuppressive effects of Gui Zhi Tang.  相似文献   
103.
104.
105.
目的检测以质粒pIRES为载体构建的带有全序列癌胚抗原(CEA)基因的核苷酸疫苗对机体特异性抗肿瘤免疫反应的激活效果。方法将CEA基因片段连接于真核表达质粒pIRES中,用肌肉注射方法接种核酸疫苗;检测CEA在小鼠肌肉组织中的表达情况及其对小鼠脾细胞CEA特异性细胞免疫反应的激活效果。结果小鼠经肌肉注射质粒后,免疫组化证实该核酸疫苗可在体内有效表达CEA;分子免疫检测显示注射后小鼠特异性淋巴细胞增值反应明显并且伴有自然杀伤细胞NK活性显著增高。结论实验所构建的核酸疫苗pIRESCEA可在体外及小鼠体内高效表达并表现出良好的细胞免疫原性。  相似文献   
106.
107.
108.
A 40-year-old man presented a painful haemorrhagic plaque on his chest in the same location where a nodular lesion had been presented for many years. After 2 months, the plaque was replaced by a depressed lesion. The lesion diagnosed as an anetoderma was excised and the biopsy showed an atrophic dermatofibroma accompanied by aneurysmatic characteristics.  相似文献   
109.
Sixteen patients (male: 14, female: 2, 41-72 yrs, mean 57.5 yrs) with OSAS were treated by nCPAP in our hospital since 1987. Respiratory disturbance index ranged from 16.5 to 83.1. The longest apnea duration was 35.0-120.5 seconds before the treatment. Two patients were treated with Sleep Easy III (Respironics Inc.) and others with a home made instruments. nCPAP was set at a pressure of 5 to 10 cm H2O. 12 patients (75%) tolerated the device but 4(25%) did not. Polysomnographic parameters before and after nCPAP therapy were compared. The longest apnea duration was 63.1 +/- 23.5 to 40.9 +/- 27.4 seconds (P less than 0.001) and the lowest saturation oxygen was 55.1 +/- 20.4% to 71.4 +/- 18.6% (P less than 0.05). The sleep structure improved but not significant statistically. One of them used nCPAP at home for more than two. years and showed a good long term effect. We concluded that nCPAP is an effective and safe treatment for OSAS. However, patients may be uncomfortable because of the wearing of the nasal mask during sleep.  相似文献   
110.
OBJECTIVES: The purpose of this study was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent atrial fibrillation (AF) converted to sinus rhythm (SR) compared with those remaining in or reverting to AF. BACKGROUND: Restoration of SR in patients with AF improving QOL and EP remains controversial. METHODS: Patients with persistent AF were randomized double-blind to amiodarone, sotalol, or placebo. Those not achieving SR at day 28 were cardioverted and classified into SR or AF groups at 8 weeks (n = 624) and 1 year (n = 556). The QOL (SF-36), symptom checklist (SCL), specific activity scale (SAS), AF severity scale (AFSS), and EP were assessed. RESULTS: Favorable changes were seen in SR patients at 8 weeks in physical functioning (p < 0.001), physical role limitations (p = 0.03), general health (p = 0.002), and vitality (p < 0.001), and at 1 year in general health (p = 0.007) and social functioning (p = 0.02). Changes in the scores for SCL severity (p = 0.01), functional capacity (p = 0.003), and AFSS symptom burden (p < 0.001) at 8 weeks and in SCL severity (p < 0.01) and AF symptom burden (p < 0.001) at 1 year showed significant improvements in SR versus AF. Symptomatic patients were more likely to have improvement. The EP in SR versus AF was greater from baseline to 8 weeks (p = 0.01) and to 1 year (p = 0.02). The EP correlated with physical functioning and functional capacity except in the AF group at 1 year. CONCLUSIONS: In patients with persistent AF, restoration and maintenance of SR was associated with improvements in QOL measures and EP. There was a strong correlation between QOL measures and EP.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号